These findings suggest that plasma Nogo-B may be a very useful surrogate marker for clinical assessment of liver fibrosis and liver function reserve in patients with chronic liver diseases with or without portal hypertension and thrombocytopenia. This evidence concerns the gene RTN4 and Hepatic fibrosis.